These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8222008)

  • 21. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of immunoconjugates composed of boanmycin and monoclonal antibody.
    Zhen Y; Peng Z; Deng Y; Xu H; Chen Y; Tian P; Li D; Jiang M
    Chin Med Sci J; 1994 Jun; 9(2):75-80. PubMed ID: 7528068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
    Chow LP; Chang KH; Lin JY
    Biochem Int; 1990 Oct; 22(1):95-102. PubMed ID: 1704234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
    Liu X; Zhen Y
    Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective killing of tumor cells in vitro by immunotoxin composed of antitumor antibiotic streptonigrin and polyclonal specific antibodies.
    Komissarenko SV; Penezina OP; Fomovskaya GN; Tolstikov VV; Preobrazhenskaya MN
    Int J Immunopharmacol; 1994 Dec; 16(12):1053-8. PubMed ID: 7705967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective cytotoxicity of an oxygen-radical-generating enzyme conjugated to a monoclonal antibody.
    Battelli MG; Abbondanza A; Tazzari PL; Dinota A; Rizzi S; Grassi G; Gobbi M; Stirpe F
    Clin Exp Immunol; 1988 Jul; 73(1):128-33. PubMed ID: 3262464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-tumor effects of bispecific monoclonal antibody targeted human monocytes-macrophages on hepatoma cells].
    Wang Q; Chen Z; Wang W
    Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):96-9. PubMed ID: 8758438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
    Wang FQ; Shang BY; Zhen YS
    Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro cytotoxicity of the conjugate adriamycin with anti-sarcoma monoclonal antibody 19-24.
    Mohamed G; Kuzmanoff KM; Stastny JJ; Das Gupta TK
    Anticancer Res; 1992; 12(2):529-32. PubMed ID: 1580569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
    Guo BC; Xu YH
    Acta Pharmacol Sin; 2001 Sep; 22(9):831-6. PubMed ID: 11749866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
    Yin Z
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance].
    Sui Y; Sun Z; Chen Z
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
    Wang F; Li S; Lin J
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
    Liu HZ; Li DD; Zhen YS; Shao RG
    Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma.
    Tang L; Sun H; Zhang L; Deng JC; Guo H; Zhang L; Liu Q
    Saudi Med J; 2009 Aug; 30(8):1001-9. PubMed ID: 19668879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies of two conjugates of monoclonal antibody (HIM6) and cytosine arabinoside].
    Wang J; Yang C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):286-90. PubMed ID: 7513267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
    Wang WG; Wang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.
    Otsuji E; Tsuruta H; Toma A; Kobayashi S; Okamoto K; Yata Y; Yamagishi H
    Hepatogastroenterology; 2003; 50(50):380-4. PubMed ID: 12749227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma.
    Galun E; Shouval D; Adler R; Shahaar M; Wilchek M; Hurwitz E; Sela M
    Hepatology; 1990 Apr; 11(4):578-84. PubMed ID: 1691730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.